CURAXIS PHARMACEUTICAL CORP Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
CURAXIS PHARMACEUTICAL CORP had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $88.86 million as of 2012-03-31, per its 10-Q filed 2012-05-14.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2012-05-14
- 2012-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $88.86M.
- 2011-12-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $88.52M.
- 2011-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$90.39M.
- 2011-06-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$90.68M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2012-03-31 | $88.86M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $88.52M 10-Q · filed 2012-05-14 | |
| 2011-09-30 | -$90.39M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | -$90.68M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $89.80M 10-K · filed 2012-03-29 | -$89.80M 10-Q · filed 2011-08-12 |